89BIO, INC. (ETNB): Price and Financial Metrics
ETNB Price/Volume Stats
| Current price | $10.25 | 52-week high | $11.84 |
| Prev. close | $9.96 | 52-week low | $4.16 |
| Day low | $10.03 | Volume | 1,583,100 |
| Day high | $10.40 | Avg. volume | 2,247,138 |
| 50-day MA | $7.75 | Dividend yield | N/A |
| 200-day MA | $8.29 | Market Cap | 1.50B |
ETNB Stock Price Chart Interactive Chart >
89BIO, INC. (ETNB) Company Bio
89bio, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for nonalcoholic steatohepatitis (NASH), liver and cardio-metabolic diseases. The company was founded on January 01, 2018 and is headquartered in San Francisco, CA.
ETNB Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ETNB Price Returns
| 1-mo | 31.58% |
| 3-mo | 30.57% |
| 6-mo | 27.65% |
| 1-year | 26.54% |
| 3-year | 159.49% |
| 5-year | -53.95% |
| YTD | 31.07% |
| 2024 | -29.99% |
| 2023 | -12.25% |
| 2022 | -2.60% |
| 2021 | -46.37% |
| 2020 | -7.30% |